I started at Lilly in April 2012 and have where I counsel the Government Strategy, Government Pricing and various commercial business functions on federal healthcare program requirements. I also review and advise our Global Public Policy and Federal and State Government Affairs teams on understanding legislative and regulatory developments likely to impact the pricing, reimbursement, and access to pharmaceuticals.
Prior to joining Lilly, I was a Senior Associate at King & Spalding where I represented and counseled Fortune 500 biopharmaceutical companies in connection with various healthcare industry issues including legal compliance with government price reporting laws, Federal Supply Schedule (FSS) contracting provisions, commercial contracting, healthcare fraud and abuse laws, and FDA regulations.
Though Lilly is based in Indianapolis, I reside in Washington D.C. I enjoy travel, wine, and reading old books.
Assistant General Counsel
Eli Lilly and Company
555 12th Street NW
Areas of Practice
Administrative & Regulatory
Drug & Medical Device
Representive, Federal Programs Focus Group (PhRMA)
Georgetown University Law Center
Update this Profile